Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study - RWTH-CONV-211202

Main document Datei(en):

h1